208 related articles for article (PubMed ID: 25232075)
1. Local administration of bone morphogenetic protein-2 and bisphosphonate during non-weight-bearing treatment of ischemic osteonecrosis of the femoral head: an experimental investigation in immature pigs.
Kim HK; Aruwajoye O; Du J; Kamiya N
J Bone Joint Surg Am; 2014 Sep; 96(18):1515-24. PubMed ID: 25232075
[TBL] [Abstract][Full Text] [Related]
2. Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head: a combined therapy that stimulates bone formation and decreases femoral head deformity.
Vandermeer JS; Kamiya N; Aya-ay J; Garces A; Browne R; Kim HK
J Bone Joint Surg Am; 2011 May; 93(10):905-13. PubMed ID: 21593365
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Transphyseal Neck-Head Tunneling and Multiple Epiphyseal Drilling on Femoral Head Healing Following Ischemic Osteonecrosis: An Experimental Investigation in Immature Pigs.
Aruwajoye OO; Monte F; Kim A; Kim HKW
J Pediatr Orthop; 2020 Apr; 40(4):168-175. PubMed ID: 32132446
[TBL] [Abstract][Full Text] [Related]
4. Effects of non-weight-bearing on the immature femoral head following ischemic osteonecrosis: an experimental investigation in immature pigs.
Kim HK; Aruwajoye O; Stetler J; Stall A
J Bone Joint Surg Am; 2012 Dec; 94(24):2228-37. PubMed ID: 23318613
[TBL] [Abstract][Full Text] [Related]
5. Material properties of bone in the femoral head treated with ibandronate and BMP-2 following ischemic osteonecrosis.
Aruwajoye OO; Aswath PB; Kim HKW
J Orthop Res; 2017 Jul; 35(7):1453-1460. PubMed ID: 27564450
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs.
Cheng TL; Murphy CM; Cantrill LC; Mikulec K; Carpenter C; Schindeler A; Little DG
Int Orthop; 2014 Jul; 38(7):1527-33. PubMed ID: 24389948
[TBL] [Abstract][Full Text] [Related]
7. Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head.
Aya-ay J; Athavale S; Morgan-Bagley S; Bian H; Bauss F; Kim HK
J Bone Miner Res; 2007 Jan; 22(1):93-100. PubMed ID: 17166092
[TBL] [Abstract][Full Text] [Related]
8. Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
Little DG; Kim HK
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S182-8. PubMed ID: 21857436
[TBL] [Abstract][Full Text] [Related]
9. Minimally Invasive Necrotic Bone Washing Improves Bone Healing After Femoral Head Ischemic Osteonecrosis: An Experimental Investigation in Immature Pigs.
Kim HKW; Park MS; Alves do Monte F; Gokani V; Aruwajoye OO; Ren Y
J Bone Joint Surg Am; 2021 Jul; 103(13):1193-1202. PubMed ID: 33877059
[TBL] [Abstract][Full Text] [Related]
10. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
Kim HK; Morgan-Bagley S; Kostenuik P
J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
[TBL] [Abstract][Full Text] [Related]
11. Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease.
Young ML; Little DG; Kim HK
Clin Orthop Relat Res; 2012 Sep; 470(9):2462-75. PubMed ID: 22270467
[TBL] [Abstract][Full Text] [Related]
12. Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs.
Kim HK; Randall TS; Bian H; Jenkins J; Garces A; Bauss F
J Bone Joint Surg Am; 2005 Mar; 87(3):550-7. PubMed ID: 15741621
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model.
Kuroyanagi G; Adapala NS; Yamaguchi R; Kamiya N; Deng Z; Aruwajoye O; Kutschke M; Chen E; Jo C; Ren Y; Kim HKW
Bone; 2018 Nov; 116():221-231. PubMed ID: 30125727
[TBL] [Abstract][Full Text] [Related]
14. Anti-Interleukin-6 Therapy Decreases Hip Synovitis and Bone Resorption and Increases Bone Formation Following Ischemic Osteonecrosis of the Femoral Head.
Ren Y; Deng Z; Gokani V; Kutschke M; Mitchell TW; Aruwajoye O; Adapala NS; Kamiya N; Abu-Amer Y; Kim HK
J Bone Miner Res; 2021 Feb; 36(2):357-368. PubMed ID: 33053220
[TBL] [Abstract][Full Text] [Related]
15. Indentation properties of growing femoral head following ischemic necrosis.
Pringle D; Koob TJ; Kim HK
J Orthop Res; 2004 Jan; 22(1):122-30. PubMed ID: 14656670
[TBL] [Abstract][Full Text] [Related]
16. Increased matrix mineralization in the immature femoral head following ischemic osteonecrosis.
Hofstaetter JG; Roschger P; Klaushofer K; Kim HK
Bone; 2010 Feb; 46(2):379-85. PubMed ID: 19833243
[TBL] [Abstract][Full Text] [Related]
17. Local bioavailability and distribution of systemically (parenterally) administered ibandronate in the infarcted femoral head.
Kim HK; Sanders M; Athavale S; Bian H; Bauss F
Bone; 2006 Jul; 39(1):205-12. PubMed ID: 16480939
[TBL] [Abstract][Full Text] [Related]
18. Low-intensity pulsed ultrasound enhances bone repair in a rabbit model of steroid-associated osteonecrosis.
Zhu H; Cai X; Lin T; Shi Z; Yan S
Clin Orthop Relat Res; 2015 May; 473(5):1830-9. PubMed ID: 25736917
[TBL] [Abstract][Full Text] [Related]
19. Biomechanical properties of bone and cartilage in growing femoral head following ischemic osteonecrosis.
Koob TJ; Pringle D; Gedbaw E; Meredith J; Berrios R; Kim HK
J Orthop Res; 2007 Jun; 25(6):750-7. PubMed ID: 17318897
[TBL] [Abstract][Full Text] [Related]
20. Intraosseous Delivery of Bone Morphogenic Protein-2 Using a Self-Assembling Peptide Hydrogel.
Phipps MC; Monte F; Mehta M; Kim HK
Biomacromolecules; 2016 Jul; 17(7):2329-36. PubMed ID: 27285121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
